References
- Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year resultsOphthalmology20121191388139822555112
- Diabetic Retinopathy Clinical Research NetworkElmanMJQinHIntravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial resultsOphthalmology20121192312231822999634
- HeierJSCampochiaroPAYauLRanibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trialOphthalmology201211980280922301066
- MichelsSRosenfeldPJPuliafitoCAMarcusENVenkatramanASSystemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical studyOphthalmology20051121035104715936441
- RosenfeldPJSchwartzSDBlumenkranzMSMaximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degenerationOphthalmology20051121048105315885778
- HeierJSAntoszykANPavanPRRanibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose studyOphthalmology2006113633.e1e416483659
- CATT Research GroupMartinDFMaguireMGRanibizumab and bevacizumab for neovascular age-related macular degenerationN Engl J Med20113641897190821526923
- MasonJO3rdWhiteMFFeistRMIncidence of acute onset endophthalmitis following intravitreal bevacizumab (Avastin) injectionRetina20082856456718398358
- FintakDRShahGKBlinderKJIncidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumabRetina2008281395139918827737
- GonzalezSRosenfeldPJStewartMWBrownJMurphySPAvastin doesn’t blind people, people blind peopleAm J Ophthalmol2012153196203.e122264942
- SheymanATCohenBZFriedmanAHAckertJMAn outbreak of fungal endophthalmitis after intravitreal injection of compounded combined bevacizumab and triamcinoloneJAMA Ophthalmol201313186486923640384
- Centers for Disease Control and PreventionCDC responds to multistate outbreak of fungal meningitis and other infections2012 Available from: http://www.cdc.gov/HAI/outbreaks/currentsituationAccessed July 30, 2013
- AlanRBergerSSSevere intraocular inflammation/endophthalmitis following off-label treatment with intravitreal bevacizumab2009 Available from: http://ophthalmologyrounds.ca/modules/contentManager/upload/document/alwaysOnLine/ScientificUpdate_en.pdfAccessed January 8, 2015
- YamashiroKTsujikawaAMiyamotoKSterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batchRetina20103048549019952993
- WickremasingheSSMichalovaKGilhotraJAcute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degenerationOphthalmology20081151911191518672291
- WangFYuSLiuKAcute intraocular inflammation caused by endotoxin after intravitreal injection of counterfeit bevacizumab in Shanghai, ChinaOphthalmology201312035536123084126
- GoldbergRAFlynnHWJrIsomRFMillerDGonzalezSAn outbreak of Streptococcus endophthalmitis after intravitreal injection of bevacizumabAm J Ophthalmol2012153204208.e122264943
- FieldenMNelsonBKheraniAAcute intraocular inflammation following intravitreal injection of bevacizumab – a large cluster of casesActa Ophthalmol201189e664e66521159147
- McCannelCAMeta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategiesRetina20113165466121330939
- WenJCMcCannelCAMochonABGarnerOBBacterial dispersal associated with speech in the setting of intravitreous injectionsArch Ophthalmol20111291551155421825179
- SimunovicMPRushRBHunyorAPChangAAEndophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomesBr J Ophthalmol20129686286622446145
- ChenELinMYCoxJBrownDMEndophthalmitis after intravitreal injection: the importance of viridans streptococciRetina2011311525153321878800
- BhavsarARStockdaleCRFerrisFL3rdBruckerAJBresslerNMGlassmanARUpdate on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibioticsArch Ophthalmol201213080981022801859
- CheungCSWongAWLuiAKertesPJDevenyiRGLamWCIncidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injectionsOphthalmology20121191609161422480743
- BhattSSStepienKEJoshiKProphylactic antibiotic use after intravitreal injection: effect on endophthalmitis rateRetina2011312032203621659941
- KimSJTomaHSOphthalmic antibiotics and antimicrobial resistance: a randomized, controlled study of patients undergoing intravitreal injectionsOphthalmology20111181358136321420176
- Miño De KasparHHoepfnerASEngelbertMAntibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit modelOphthalmology200110847047811237900
- AbellRGKerrNMAllenPVoteBJIntravitreal injections: is there benefit for a theatre setting?Br J Ophthalmol2012961474147823018424
- LiTDickersinKCitation of previous meta-analyses on the same topic: a clue to perpetuation of incorrect methods?Ophthalmology20131201113111923522971